@article{Swallow_2016, title={Is Robenacoxib Superior to Meloxicam in Improving Patient Comfort in Dogs Diagnosed With a Degenerative Joint Process?}, volume={1}, url={https://veterinaryevidence.org/index.php/ve/article/view/17}, DOI={10.18849/ve.v1i1.17}, abstractNote={<p><span lang="EN-US" style="font-family: ’Arial’,’sans-serif’; font-size: 12pt; mso-fareast-font-family: ’Arial Unicode MS’; mso-hansi-font-family: ’Times New Roman’; mso-bidi-font-family: ’Times New Roman’; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;"><strong>Clinical bottom line</strong></span></p> <p><span lang="EN-US" style="font-family: ’Arial’,’sans-serif’; font-size: 12pt; mso-fareast-font-family: ’Arial Unicode MS’; mso-hansi-font-family: ’Times New Roman’; mso-bidi-font-family: ’Times New Roman’; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">At normal clinical doses, there is no evidence that robenacoxib would provide superior patient comfort compared to meloxicam.</span></p>}, number={1}, journal={Veterinary Evidence}, author={Swallow, Adam}, year={2016}, month={Jan.} }